NZ202404A - Acylmorphinan derivatives and pharmaceutical compositions containing such - Google Patents

Acylmorphinan derivatives and pharmaceutical compositions containing such

Info

Publication number
NZ202404A
NZ202404A NZ202404A NZ20240482A NZ202404A NZ 202404 A NZ202404 A NZ 202404A NZ 202404 A NZ202404 A NZ 202404A NZ 20240482 A NZ20240482 A NZ 20240482A NZ 202404 A NZ202404 A NZ 202404A
Authority
NZ
New Zealand
Prior art keywords
compound
lower alkyl
alkyl
acetyl
accordance
Prior art date
Application number
NZ202404A
Other languages
English (en)
Inventor
E Mohacsi
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ202404A publication Critical patent/NZ202404A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NZ202404A 1981-11-09 1982-11-05 Acylmorphinan derivatives and pharmaceutical compositions containing such NZ202404A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/319,482 US4374139A (en) 1981-11-09 1981-11-09 Levorotatory N-substituted acylmorphinans useful as analgesic agents

Publications (1)

Publication Number Publication Date
NZ202404A true NZ202404A (en) 1985-11-08

Family

ID=23242421

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ202404A NZ202404A (en) 1981-11-09 1982-11-05 Acylmorphinan derivatives and pharmaceutical compositions containing such

Country Status (18)

Country Link
US (1) US4374139A (OSRAM)
EP (1) EP0079556A3 (OSRAM)
JP (1) JPS5888364A (OSRAM)
KR (1) KR840002357A (OSRAM)
AU (1) AU9027682A (OSRAM)
CA (1) CA1195324A (OSRAM)
DK (1) DK491582A (OSRAM)
ES (2) ES517222A0 (OSRAM)
FI (1) FI823824L (OSRAM)
GR (1) GR78317B (OSRAM)
HU (1) HU187425B (OSRAM)
IL (1) IL67180A0 (OSRAM)
MC (1) MC1490A1 (OSRAM)
NO (1) NO823707L (OSRAM)
NZ (1) NZ202404A (OSRAM)
PH (1) PH18458A (OSRAM)
PT (1) PT75815B (OSRAM)
ZA (1) ZA827905B (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423221A (en) * 1982-06-10 1983-12-27 Sisa Pharmaceutical Laboratories, Inc. 7-Carboethoxy-morphinan-6-one compounds
US4454141A (en) * 1982-09-23 1984-06-12 Sisa Pharmaceutical Laboratories, Inc. Trans-B/C-7-(1-hydroxypentyl)-3-methoxy-17 methyl-6,7-didehydromorphinans, and methods of relieving pain with them
EP0184041A1 (en) * 1984-11-13 1986-06-11 Miles Inc. 6-Methylene morphinan purification technique
US4929622A (en) * 1987-09-24 1990-05-29 Hoechst-Roussel Pharmaceuticals, Inc. 2,6-Methanopyrrolo-3-benzazocines
DE4304450A1 (de) * 1993-02-13 1994-08-18 Boehringer Mannheim Gmbh System zur Zubereitung von Flüssigkeiten
WO2002036573A2 (en) * 2000-10-31 2002-05-10 Rensselaer Polytechnic Institute 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20040204862A1 (en) * 2003-04-11 2004-10-14 Wainer Irving W. Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
PT2506712T (pt) 2009-12-04 2019-05-31 Alkermes Pharma Ireland Ltd Derivados de morfinano para o tratamento da overdose por fármaco
ES2582306T3 (es) 2010-03-22 2016-09-12 Rensselaer Polytechnic Institute Derivados de morfinano que contienen un grupo carboxamida como ligandos de receptores opioides
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
HUE034326T2 (en) 2011-06-29 2018-02-28 Alkermes Inc Peripherally acting opioid compounds
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
JP2016519161A (ja) 2013-05-24 2016-06-30 アルカームス ファーマ アイルランド リミテッド モルファン及びモルフィナン類似物及び使用の方法
US9656961B2 (en) 2013-05-24 2017-05-23 Alkermes Pharma Ireland Limited Methods for treating depressive symptoms
WO2018125716A1 (en) * 2017-01-02 2018-07-05 Purdue Pharma L.P. Morphinan derivatives and use thereof
WO2022101444A1 (en) 2020-11-12 2022-05-19 Alkermes Pharma Ireland Limited Immediate release multilayer tablet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723437A (en) * 1970-09-15 1973-03-27 American Home Prod 4,10-(methaniminomethano phenanthrene derivatives
ZA73988B (en) * 1972-03-10 1973-10-31 Hoffmann La Roche Morphinan derivatives
US3914233A (en) * 1972-10-20 1975-10-21 Hoffmann La Roche 4-Hydroxy-N-substituted morphinan derivatives

Also Published As

Publication number Publication date
KR840002357A (ko) 1984-06-25
ES8506635A1 (es) 1985-08-01
AU9027682A (en) 1983-05-19
IL67180A0 (en) 1983-03-31
ES8500948A1 (es) 1984-12-01
FI823824A0 (fi) 1982-11-08
EP0079556A2 (de) 1983-05-25
FI823824A7 (fi) 1983-05-10
MC1490A1 (fr) 1983-09-12
PT75815A (en) 1982-12-01
GR78317B (OSRAM) 1984-09-26
PH18458A (en) 1985-07-18
US4374139A (en) 1983-02-15
HU187425B (en) 1986-01-28
ZA827905B (en) 1983-08-31
EP0079556A3 (de) 1983-08-24
DK491582A (da) 1983-05-10
NO823707L (no) 1983-05-10
PT75815B (en) 1986-01-21
JPS5888364A (ja) 1983-05-26
CA1195324A (en) 1985-10-15
ES529349A0 (es) 1985-08-01
ES517222A0 (es) 1984-12-01
FI823824L (fi) 1983-05-10

Similar Documents

Publication Publication Date Title
NZ202404A (en) Acylmorphinan derivatives and pharmaceutical compositions containing such
US4912114A (en) Morphinan derivatives
JPS6350354B2 (OSRAM)
GB2097387A (en) 3,4-dihydro-5h-2,3-benzodiazepine derivatives
EP0046666B1 (en) 2(3h)-indolones, process for their preparation and compositions containing them
GB2175898A (en) Morphinan derivatives
EP0162695A1 (en) 6-Oxygenated-1,3,,4,5-Tetrahydrobenz(cd)indol-4-amines
EP0028717B1 (en) 6,7-benzomorphan derivatives, processes for their production, pharmaceutical compositions containing said derivatives and their use as pharmaceuticals
WO1988007858A1 (en) Sulfinyl and sulfonyl substituted 3-benzazepines
US3557127A (en) Substituted cyclohexenes,derivatives thereof and processes for obtaining same
GB1569251A (en) Pyridobenzodiazepines
CA1100136A (en) 4a-aryl octahydro-1h-2-pyrindines
KR900004148B1 (ko) 피롤로[1,2-a][4,1]벤즈옥사제핀 유도체
EP0118565B1 (en) 1,4-methano-2-benzazepine derivatives
US4533662A (en) 2-Acylaminomethyl-1,4-benzodiazepine compounds and analgesic use
GB1588337A (en) Benzo-fused xanthenes thioxanthenes and dibenzoxepines and processes for their preparation
US4247697A (en) 3-Phenoxy morphinans and their derivatives
US4194044A (en) Process for preparing 3-phenoxy morphinans
EP0491549B1 (en) Novel 15-nitro-2beta, 3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives, pharmaceutical compositions containing them and process for preparing same
US4163853A (en) 1-(P-phenoxy)benzyl-1,2,3,4,5,6,7,8-octahydroisoquinolines
EP0018077A2 (en) Phenylmorphans, processes for their preparation and pharmaceutical compositions containing them
EP0077536A2 (en) 2'-Substituted-spiro(benzofuran-2(3H),1'-cycloalkanes), a process for preparing same, pharmaceutical compositions containing such compounds and their use as medicaments
US3047571A (en) Derivatives of oxopiperidinyl phenthiazines
US3950346A (en) Novel process for producing 2-ketoethylbenzomorphan derivatives and salts thereof
GB1566846A (en) Benzothiophene derivatives